drug
as of 2026-07-01Wellness education
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by Eli Lilly and Company
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
BEHAVIORAL
Indications
Investigational (via trials)
Trials
1
Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine
NCT00401973Phase 3Completed
KOLs & investigators
1
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication
indication
indication